Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01660906
Title This Study Will be a Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

chronic myeloid leukemia

Therapies

Dasatinib

Age Groups: adult
Covered Countries USA | ITA | FRA | DEU

Facility Status City State Zip Country Details
Pacific Cancer Medical Center Anaheim California 92801 United States Details
Cancer Center Of Central Connecticut Southington Connecticut 06489 United States Details
St. Agnes Healthcare, Inc. Baltimore Maryland 21229 United States Details
Promedica Hematology & Oncology Assoicates Sylvania Ohio 43560 United States Details
The University Of Texas Md Anderson Cancer Center Houston Texas 77030 United States Details
Local Institution Creteil Cedex 94010 France Details
Local Institution Lille CEDEX 59037 France Details
Local Institution Pierre Benite cedex 69495 France Details
Local Institution Pringy Cedex 74374 France Details
Local Institution Vandoeuvre les Nancy 54511 France Details
Local Institution Jena 07747 Germany Details
Local Institution Koln 50937 Germany Details
Local Institution Lubeck 23562 Germany Details
Local Institution Mannheim 68169 Germany Details
Local Institution Rostock 18055 Germany Details
Local Institution Catania 95124 Italy Details
Local Institution Firenze 50134 Italy Details
Local Institution Napoli 80131 Italy Details
Local Institution Roma 00144 Italy Details
Local Institution Roma 00161 Italy Details
Local Institution Torino 10126 Italy Details
Local Institution Seoul 137-701 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field